美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Splash Beverage Group Inc.

0.4182

+0.03278.48%

盤後：0.3877-0.0305-7.29%18:38 EDT

成交量：171.69萬

成交額：72.53萬

市值：263.47萬

市盈率：-0.03

高：0.4599

開：0.3877

低：0.3877

收：0.3855

52周最高：13.40

52周最低：0.2500

股本：630.00萬

流通股本：630.00萬

量比：1.82

換手率：27.25%

股息：- -

股息率：- -

每股收益(TTM):-13.7234

每股收益(LYR):-70.9984

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):-0.01

資料載入中...

總覽公司新聞資訊公告

Endovia Health Sciences：首推Cannepil，聚焦伴侶動物癌症疼痛，從犬類腫瘤學起步

Endovia Health Sciences：擬依據FDA「次要用途/次要物種」認定及附條件批准途徑推進研發

Endovia Health Sciences（前Splash Beverage）Cannepil®獸用開發項目達成FDA首個監管里程碑

Splash Beverage Group宣佈將啓用新股票代碼Edva，並推出Endoviasciences.com網站——SEC文件披露

Splash Beverage Group 宣佈更名：自2026年8月24日起，將正式更名為 Endovia Health Sciences

Splash Beverage Group 提交招股説明書：持股股東計劃轉售最多500萬股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/EDVA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EDVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","market":"US","secType":"STK","nameCN":"Splash Beverage Group Inc.","latestPrice":0.4182,"timestamp":1787688000000,"preClose":0.3855,"halted":0,"volume":1716886,"hourTrading":{"tag":"盘后","latestPrice":0.3877,"preClose":0.4182,"latestTime":"18:38 EDT","volume":55371,"amount":21920.7642819,"timestamp":1787697501041,"change":-0.0305,"changeRate":-0.072932,"amplitude":0.072932},"delay":0,"changeRate":0.08482490272373543,"floatShares":6300000,"shares":6300000,"eps":-13.723449,"marketStatus":"盤後交易","change":0.0327,"latestTime":"08-25 18:51:40 EDT","open":0.3877,"high":0.4599,"low":0.3877,"amount":725304.5856453,"amplitude":0.187289,"askPrice":0.4299,"askSize":100,"bidPrice":0.3877,"bidSize":94,"shortable":0,"etf":0,"ttmEps":-13.723449,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"exchange":"AMEX","adjPreClose":0.3855,"preHourTrading":{"tag":"盘前","latestPrice":0.3897,"preClose":0.3855,"latestTime":"09:22 EDT","volume":199891,"amount":79496.6107218,"timestamp":1787664146566,"change":0.0042,"changeRate":0.010895,"amplitude":0.159014},"postHourTrading":{"tag":"盘后","latestPrice":0.3877,"preClose":0.4182,"latestTime":"18:38 EDT","volume":55371,"amount":21920.7642819,"timestamp":1787697501041,"change":-0.0305,"changeRate":-0.072932,"amplitude":0.072932},"volumeRatio":1.817324},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","floatShares":6300000,"roa":"--","roe":"--","lyrEps":-70.998368,"volumeRatio":1.817324,"shares":6300000,"dividePrice":0,"high":0.4599,"amplitude":0.187289,"preClose":0.3855,"low":0.3877,"week52Low":0.25,"pbRate":"--","week52High":13.3996,"institutionHeld":0,"latestPrice":0.4182,"committee":-0.030928,"eps":-13.723449,"divideRate":0,"volume":1716886,"delay":0,"ttmEps":-13.723449,"open":0.3877,"prevYearClose":2.7616,"prevWeekClose":0.4715,"prevMonthClose":0.37,"prevQuarterClose":0.62,"fiveDayClose":0.3987,"twentyDayClose":0.3526,"sixtyDayClose":0.6856},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EDVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-19","symbol":"EDVA","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1787112000000,"reportTimeType":"post","actualEps":-0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EDVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EDVA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EDVA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1187898799","title":"Endovia Health Sciences：首推Cannepil，聚焦伴侶動物癌症疼痛，從犬類腫瘤學起步","url":"https://stock-news.laohu8.com/highlight/detail?id=1187898799","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187898799?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 20:32","pubTimestamp":1787661162,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences公司宣布，其初期战略将锁定Cannepil这一产品，专门用于缓解伴侣动物因癌症引发的疼痛。而这一计划的起点，正是犬类肿瘤治疗领域。伴侣动物的癌症疼痛管理，长期面临方案匮乏的困境。Endovia此番入局，显然意在填补这一空白。Cannepil作为核心产品，其定位清晰：直击癌症相关疼痛，而非泛泛的镇痛市场。目前，Endovia尚未透露Cannepil的具体上市时间表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107920718","title":"Endovia Health Sciences：擬依據FDA「次要用途/次要物種」認定及附條件批准途徑推進研發","url":"https://stock-news.laohu8.com/highlight/detail?id=1107920718","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107920718?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 20:32","pubTimestamp":1787661162,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences宣布，其有意在美国食品药品监督管理局的“次要用途/次要物种”认定框架下，推动相关产品的研发工作，并计划采用该机构设定的附条件批准路径。Endovia Health Sciences尚未披露具体的候选产品细节，但明确表达了其致力于在这一特殊监管框架内，探索并推进创新疗法的坚定意向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183316075","title":"Endovia Health Sciences（前Splash Beverage）Cannepil®獸用開發項目達成FDA首個監管里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1183316075","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183316075?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 20:31","pubTimestamp":1787661071,"startTime":"0","endTime":"0","summary":"Endovia Health Sciences（前身为Splash Beverage Group Inc.）宣布，其Cannepil®兽用开发项目已成功达成美国食品药品监督管理局（FDA）的首个监管里程碑。这一进展标志着该公司在兽用医疗领域迈出了关键一步，为其后续研发及商业化进程奠定了坚实基础。据悉，此次里程碑的达成，是Endovia Health Sciences战略转型的重要成果，也彰显了其在生命科学领域的深耕决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128381110","title":"Splash Beverage Group宣佈將啓用新股票代碼Edva，並推出Endoviasciences.com網站——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1128381110","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128381110?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 20:56","pubTimestamp":1786539405,"startTime":"0","endTime":"0","summary":"Splash Beverage Group Inc.（股票代码：SBEV）即将迎来重大变革。根据美国证券交易委员会（SEC）提交的文件，这家公司计划更换其股票代码，采用全新的“Edva”作为标识。与此同时，企业还将同步上线一个独立域名网站——Endoviasciences.com。这一系列动作背后，或许预示着公司战略重心的转移或业务版图的扩张。市场对此消息反应如何？后续发展值得关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4169","EDVA","BK4113","SBEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113650280","title":"Splash Beverage Group 宣佈更名：自2026年8月24日起，將正式更名為 Endovia Health Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=1113650280","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113650280?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 20:43","pubTimestamp":1786538589,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件，Splash Beverage Group Inc.（股票代码：SBEV）正式对外宣布，公司即将迎来一次重大品牌重塑。从2026年8月24日起，这家公司将以全新的名称——“Endovia Health Sciences” 亮相资本市场。此项更名决定，标志着公司战略方向的一次关键转变，从传统的饮料领域向健康科学领域拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBEV","BK4169","BK4113","EDVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169976339","title":"Splash Beverage Group 提交招股説明書：持股股東計劃轉售最多500萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=1169976339","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169976339?lang=zh_tw&edition=fundamental","pubTime":"2026-08-08 04:06","pubTimestamp":1786133174,"startTime":"0","endTime":"0","summary":"Splash Beverage Group 已向美国证券交易委员会（SEC）提交了一份招股说明书。该文件显示，公司的一位持股股东计划转售最多500万股股份。这一举动通常意味着现有股东希望套现，而非公司直接发行新股以筹集资金。不过，此类文件仍需经历SEC的审核流程，最终是否实施及具体数量仍存变数。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","BK4169","EDVA","SBEV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}